TAT-N15 is a p55PIK inhibitor with remarkable anti-inflammatory activity and neuroprotective effects. TAT-N15 can significantly inhibit the activation of IL-6, IL-8, Akt, and NF-kappaB pathways, as well as suppress the protein expression of phosphorylated STAT3 and NF-kappaB. By inhibiting the activation of Akt, STAT3, and NF-kappaB pathways, TAT-N15 is used in research on acute conjunctivitis, allergic rhinitis, chronic obstructive pulmonary disease (COPD), and stroke[1][2].
Molecular Weight:
3522.14
CAS Number:
[2415370-74-8]
Formula:
C155H250N48O40S3
Target:
Akt,Interleukin Related,NF-kappaB,STAT
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted
